ECTE Share Price

Open 0.01 Change Price %
High 0.01 1 Day 0.00 0.00
Low 0.01 1 Week 0.00 0.00
Close 0.01 1 Month -0.01 -50.00
Volume 88587 1 Year -0.36 -97.30
52 Week High 0.39
52 Week Low 0.00
ECTE Important Levels
Resistance 2 0.01
Resistance 1 0.01
Pivot 0.01
Support 1 0.01
Support 2 0.01
NASDAQ USA Most Active Stocks
YHOO 52.58 0.00%
YHOO 52.58 0.00%
YHOO 52.58 0.00%
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
MU 44.31 6.39%
MU 44.31 6.39%
MU 44.31 6.39%
RIMM 13.03 0.39%
More..
NASDAQ USA Top Gainers Stocks
LOCM 0.09 50.00%
SCHS 0.04 33.33%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
HLIT 3.70 25.42%
OTT 2.39 25.13%
QNST 8.90 20.76%
VRTA 4.00 19.40%
SNSS 2.56 19.07%
GCFB 0.44 18.92%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
GMETP 0.15 -76.92%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
TRGT 0.96 -41.46%
More..

Echo Therapeutics, Inc. (NASDAQ: ECTE)

ECTE Technical Analysis 5
As on 31st Oct 2017 ECTE Share Price closed @ 0.01 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.12 & Strong Sell for SHORT-TERM with Stoploss of 0.03 we also expect STOCK to react on Following IMPORTANT LEVELS.
ECTE Target for December
1st Target up-side 0.03
2nd Target up-side 0.04
3rd Target up-side 0.05
1st Target down-side -0.01
2nd Target down-side -0.02
3rd Target down-side -0.03
ECTE Other Details
Segment EQ
Market Capital 56570792.00
Sector Healthcare
Industry Drug Manufacturers - Major
Offical website http://www.echotx.com
ECTE Address
ECTE
8 Penn Center
1628 JFK Boulevard
Philadelphia, PA 19103
United States
Phone: 215-717-4100
ECTE Latest News
Interactive Technical Analysis Chart Echo Therapeutics, Inc. ( ECTE NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Echo Therapeutics, Inc.
ECTE Business Profile
Echo Therapeutics, Inc. (Echo) is a transdermal medical device company. The Company is developing Prelude SkinPrep System (Prelude) as a technology to allow for painless and skin permeation that enable both analyte extraction and needle-free drug delivery. The Company is developing its Symphony CGM System (Symphony) as a non-invasive, wireless continuous glucose monitoring (CGM) system for use in hospital critical care units and for people with diabetes. The Prelude SkinPrep System (Prelude), a component of its Symphony CGM System, allows for skin permeation that enables extraction of analytes such as glucose. Prelude�s platform skin preparation technology also allows for needle-free, transdermal drug delivery.